MX9202466A - Compuestos inmunosupresores novedosos. - Google Patents
Compuestos inmunosupresores novedosos.Info
- Publication number
- MX9202466A MX9202466A MX9202466A MX9202466A MX9202466A MX 9202466 A MX9202466 A MX 9202466A MX 9202466 A MX9202466 A MX 9202466A MX 9202466 A MX9202466 A MX 9202466A MX 9202466 A MX9202466 A MX 9202466A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- immunosuppressive
- immunosuppressive compounds
- rotamase
- novelty
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000001506 immunosuppresive effect Effects 0.000 title abstract 3
- 101710103508 FK506-binding protein Proteins 0.000 abstract 2
- 101710104425 FK506-binding protein 2 Proteins 0.000 abstract 2
- 101710104423 FK506-binding protein 3 Proteins 0.000 abstract 2
- 101710104333 FK506-binding protein 4 Proteins 0.000 abstract 2
- 101710104342 FK506-binding protein 5 Proteins 0.000 abstract 2
- 101710149710 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 101710121306 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 101710180800 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA Proteins 0.000 abstract 2
- 101710104030 Long-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 101710114693 Outer membrane protein MIP Proteins 0.000 abstract 2
- 101710116692 Peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 101710111764 Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 abstract 2
- 101710111749 Peptidyl-prolyl cis-trans isomerase FKBP11 Proteins 0.000 abstract 2
- 101710111747 Peptidyl-prolyl cis-trans isomerase FKBP12 Proteins 0.000 abstract 2
- 101710111757 Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 abstract 2
- 101710111682 Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 abstract 2
- 101710111689 Peptidyl-prolyl cis-trans isomerase FKBP1B Proteins 0.000 abstract 2
- 101710147154 Peptidyl-prolyl cis-trans isomerase FKBP2 Proteins 0.000 abstract 2
- 101710147149 Peptidyl-prolyl cis-trans isomerase FKBP3 Proteins 0.000 abstract 2
- 101710147152 Peptidyl-prolyl cis-trans isomerase FKBP4 Proteins 0.000 abstract 2
- 101710147150 Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 abstract 2
- 101710147138 Peptidyl-prolyl cis-trans isomerase FKBP7 Proteins 0.000 abstract 2
- 101710147137 Peptidyl-prolyl cis-trans isomerase FKBP8 Proteins 0.000 abstract 2
- 101710147136 Peptidyl-prolyl cis-trans isomerase FKBP9 Proteins 0.000 abstract 2
- 102100038809 Peptidyl-prolyl cis-trans isomerase FKBP9 Human genes 0.000 abstract 2
- 101710174853 Peptidyl-prolyl cis-trans isomerase Mip Proteins 0.000 abstract 2
- 101710200991 Peptidyl-prolyl cis-trans isomerase, rhodopsin-specific isozyme Proteins 0.000 abstract 2
- 101710092145 Peptidyl-prolyl cis-trans isomerase-like 1 Proteins 0.000 abstract 2
- 101710092146 Peptidyl-prolyl cis-trans isomerase-like 2 Proteins 0.000 abstract 2
- 101710092148 Peptidyl-prolyl cis-trans isomerase-like 3 Proteins 0.000 abstract 2
- 101710092149 Peptidyl-prolyl cis-trans isomerase-like 4 Proteins 0.000 abstract 2
- 101710113444 Probable parvulin-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 101710090737 Probable peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 101710133309 Putative peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 101710124237 Short-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102000003813 Cis-trans-isomerases Human genes 0.000 abstract 1
- 108090000175 Cis-trans-isomerases Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000006044 T cell activation Effects 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 230000004520 agglutination Effects 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 229940124589 immunosuppressive drug Drugs 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a una clase novedosa de compuestos inmunosupresores que tiene una afinidad para la proteína de aglutinación FK-506 (PAKF). Una vez enlazados con esta proteína, los compuestos inmunosupresores inhiben la actividad de la isomerasa cistrans del prolilpeptidilo (rotamasa) de la PAFK, e inhiben la activación de la célula T. Como tales, los compuestos de la presente invención se pueden utilizar como fármacos inmunosupresores para prevenir o reducir significativamente el rechazo de injerto en los trasplantes de médula ósea y de órganos, y para utilizarse en el tratamiento de una amplia variedad de enfermedades autoinmunes en seres humanos y en otros mamíferos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70537191A | 1991-05-24 | 1991-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9202466A true MX9202466A (es) | 1994-06-30 |
Family
ID=24833176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9202466A MX9202466A (es) | 1991-05-24 | 1992-05-25 | Compuestos inmunosupresores novedosos. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0587756A1 (es) |
| JP (1) | JP3163104B2 (es) |
| AU (1) | AU2185092A (es) |
| CA (1) | CA2102178A1 (es) |
| MX (1) | MX9202466A (es) |
| WO (1) | WO1992021313A2 (es) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798355A (en) * | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
| US5846981A (en) * | 1993-05-28 | 1998-12-08 | Gpi Nil Holdings Inc. | Inhibitors of rotamase enzyme activity |
| US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| US7056935B2 (en) | 1995-06-07 | 2006-06-06 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
| GB2324527B (en) * | 1995-06-07 | 1999-12-22 | Guilford Pharm Inc | Small molecule inhibitors of rotamase enzyme activity |
| US5707985A (en) * | 1995-06-07 | 1998-01-13 | Tanabe Seiyaku Co. Ltd. | Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators |
| US5696135A (en) * | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
| US5801197A (en) * | 1995-10-31 | 1998-09-01 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
| FR2750087B1 (fr) * | 1996-06-19 | 1998-09-04 | Faure Bertrand Equipements Sa | Element de siege de vehicule comportant une coiffe tendue sur une armature metallique |
| US5786378A (en) * | 1996-09-25 | 1998-07-28 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters |
| US5801187A (en) | 1996-09-25 | 1998-09-01 | Gpi-Nil Holdings, Inc. | Heterocyclic esters and amides |
| US6218424B1 (en) | 1996-09-25 | 2001-04-17 | Gpi Nil Holdings, Inc. | Heterocyclic ketone and thioester compounds and uses |
| JP2002515050A (ja) * | 1996-12-31 | 2002-05-21 | ジーピーアイ エヌアイエル ホールディングス インコーポレイテッド | ヘテロ環式チオエステルのn−結合尿素およびカルバメート |
| US5935989A (en) * | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
| US5721256A (en) * | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
| US5846979A (en) * | 1997-02-28 | 1998-12-08 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| US6274602B1 (en) | 1998-06-03 | 2001-08-14 | Gpi Nil Holdings, Inc. | Heterocyclic thioester and ketone hair growth compositions and uses |
| US6187796B1 (en) | 1998-06-03 | 2001-02-13 | Gpi Nil Holdings, Inc. | Sulfone hair growth compositions and uses |
| US20010049381A1 (en) | 1997-06-04 | 2001-12-06 | Gpl Nil Holdings, Inc., | Pyrrolidine derivative hair growth compositions and uses |
| US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
| US6187784B1 (en) | 1998-06-03 | 2001-02-13 | Gpi Nil Holdings, Inc. | Pipecolic acid derivative hair growth compositions and uses |
| US6271244B1 (en) | 1998-06-03 | 2001-08-07 | Gpi Nil Holdings, Inc. | N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses |
| US6852496B1 (en) | 1997-08-12 | 2005-02-08 | Oregon Health And Science University | Methods of screening for agents that promote nerve cell growth |
| EP1007521A1 (en) * | 1997-08-29 | 2000-06-14 | Vertex Pharmaceuticals Incorporated | Compounds possessing neuronal activity |
| US6268384B1 (en) | 1997-08-29 | 2001-07-31 | Vertex Pharmaceuticals Incorporated | Compounds possessing neuronal activity |
| DE19742263A1 (de) * | 1997-09-25 | 1999-04-01 | Asta Medica Ag | Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva |
| US5968921A (en) | 1997-10-24 | 1999-10-19 | Orgegon Health Sciences University | Compositions and methods for promoting nerve regeneration |
| GB9804426D0 (en) * | 1998-03-02 | 1998-04-29 | Pfizer Ltd | Heterocycles |
| CA2333997A1 (en) | 1998-06-02 | 1999-12-09 | Bristol-Myers Squibb Company | Neurotrophic difluoroamide agents |
| US6172087B1 (en) | 1998-06-03 | 2001-01-09 | Gpi Nil Holding, Inc. | N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses |
| US6331537B1 (en) | 1998-06-03 | 2001-12-18 | Gpi Nil Holdings, Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| US7459473B2 (en) * | 1998-06-03 | 2008-12-02 | Glia Med, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| EP1085853A1 (en) | 1998-06-03 | 2001-03-28 | GPI NIL Holdings, Inc. | Heterocyclic ester and amide hair growth compositions and uses |
| GB9815880D0 (en) | 1998-07-21 | 1998-09-16 | Pfizer Ltd | Heterocycles |
| US7338976B1 (en) * | 1998-08-14 | 2008-03-04 | Gpi Nil Holdings, Inc. | Heterocyclic esters or amides for vision and memory disorders |
| US6218423B1 (en) | 1998-08-14 | 2001-04-17 | Gpi Nil Holdings, Inc. | Pyrrolidine derivatives for vision and memory disorders |
| US6337340B1 (en) | 1998-08-14 | 2002-01-08 | Gpi Nil Holdings, Inc. | Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| US6339101B1 (en) | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| US6384056B1 (en) | 1998-08-14 | 2002-05-07 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters or ketones for vision and memory disorders |
| US6395758B1 (en) | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
| US6335348B1 (en) | 1998-08-14 | 2002-01-01 | Gpi Nil Holdings, Inc. | Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders |
| US6376517B1 (en) | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
| US6333340B1 (en) | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
| US6506788B1 (en) | 1998-08-14 | 2003-01-14 | Gpi Nil Holdings, Inc. | N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| US6399648B1 (en) | 1998-08-14 | 2002-06-04 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| US7265150B1 (en) * | 1998-08-14 | 2007-09-04 | Gpi Nil Holdings Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders |
| US6462072B1 (en) | 1998-09-21 | 2002-10-08 | Gpi Nil Holdings, Inc. | Cyclic ester or amide derivatives |
| US6307049B1 (en) | 1998-09-30 | 2001-10-23 | The Procter & Gamble Co. | Heterocyclic 2-substituted ketoamides |
| US6300341B1 (en) | 1998-09-30 | 2001-10-09 | The Procter & Gamble Co. | 2-substituted heterocyclic sulfonamides |
| US6228872B1 (en) | 1998-11-12 | 2001-05-08 | Bristol-Myers Squibb Company | Neurotrophic diamide and carbamate agents |
| US6734211B1 (en) | 1999-07-09 | 2004-05-11 | Oregon Health & Sciences University | Compositions and methods for promoting nerve regeneration |
| WO2001010837A1 (en) * | 1999-08-05 | 2001-02-15 | The Procter & Gamble Company | Multivalent sulfonamides |
| AU6499000A (en) * | 1999-08-05 | 2001-03-05 | Procter & Gamble Company, The | Multivalent compounds |
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| US6417189B1 (en) | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| EP1244670B1 (en) | 1999-12-21 | 2006-03-08 | MGI GP, Inc. | Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
| CN110054665B (zh) * | 2019-04-29 | 2022-08-26 | 湖南新汇制药股份有限公司 | 一种环五肽化合物在制备免疫抑制剂药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3424749A (en) | 1965-06-23 | 1969-01-28 | Heinz A Pfenninger | Certain n-(benzenesulfonyl) pipecolinic acids and lower alkyl esters thereof |
| DE2431734A1 (de) * | 1974-07-02 | 1976-01-29 | Basf Ag | Beta-ketopropan-sultone und -sultame |
| JPS6137764A (ja) * | 1984-07-31 | 1986-02-22 | Suntory Ltd | 抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物 |
| JP2691442B2 (ja) * | 1989-02-20 | 1997-12-17 | 株式会社ヤクルト本社 | 新規なプロリン誘導体 |
| US5192773A (en) * | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
-
1992
- 1992-05-25 MX MX9202466A patent/MX9202466A/es unknown
- 1992-05-26 WO PCT/US1992/004391 patent/WO1992021313A2/en not_active Ceased
- 1992-05-26 JP JP50049793A patent/JP3163104B2/ja not_active Expired - Fee Related
- 1992-05-26 EP EP92913385A patent/EP0587756A1/en not_active Withdrawn
- 1992-05-26 CA CA002102178A patent/CA2102178A1/en not_active Abandoned
- 1992-05-26 AU AU21850/92A patent/AU2185092A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0587756A1 (en) | 1994-03-23 |
| WO1992021313A3 (en) | 1993-01-07 |
| JPH06508141A (ja) | 1994-09-14 |
| AU2185092A (en) | 1993-01-08 |
| JP3163104B2 (ja) | 2001-05-08 |
| WO1992021313A2 (en) | 1992-12-10 |
| CA2102178A1 (en) | 1992-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9202466A (es) | Compuestos inmunosupresores novedosos. | |
| ES2137186T3 (es) | Nuevos compuestos inmunosupresores. | |
| ATE159247T1 (de) | Immunosuppressive verbindungen | |
| ATE163420T1 (de) | C-22 ringstabilisierte rapamycin derivate | |
| NL300056I1 (nl) | Toepassing van rapamycine en derivaten en vóórgeneesmiddelen daarvan bij de bereiding van een geneesmiddel voor het remmen van de afstoting van een transplantaat in zoogdieren. | |
| BR9306345A (pt) | Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune | |
| GT199700089A (es) | Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido. | |
| MX9306271A (es) | Carbamatos de rapamicina y composicion farmaceutica que los incluye. | |
| ES2054747T3 (es) | Nuevos antidepresivos. | |
| ES2161697T3 (es) | Peptidos agonistas de amilina y usos de los mismos. | |
| BR0114390A (pt) | éteres de 7-desmetilrapamicina | |
| ES2182112T3 (es) | Composiciones farmaceuticas para el tratamiento del rechazo de transplantes y de estados autoinmunes o inflamatorios, que comprenden ciclosporina a y 40-o-(2-hidroxietil)-rapamicina. | |
| LTC1131065I2 (lt) | Dialkilfumaratai, skirti autoimuninėms ligoms gydyti | |
| MX2019002288A (es) | Suspensión celular para usarse en el tratamiento de la arteriopatía periférica de las extremidades inferiores. | |
| CO5050328A1 (es) | Sistema solvente para la mejor penetracion de compuestos farmaceuticos | |
| DK0408711T3 (da) | S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer | |
| ATE246003T1 (de) | Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion | |
| DK0542860T3 (da) | Immunosuppressive sammensætninger | |
| WO1993006852A3 (en) | Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein | |
| ES2075014T3 (es) | Derivados de progesterona 19-sustituidos utiles como inhibidores de 19-hidroxilasa. | |
| NZ237739A (en) | Pharmaceutical composition of a complement inhibitor and an immunosuppressant with cyclosporin a-like activity, and its use | |
| Yokoyama et al. | Role of lymphocyte activation by substance P in rheumatoid arthritis | |
| DK0697876T3 (da) | Xenograftthymus | |
| Yocheva | Pacta Sunt Servanda | |
| Bäckman et al. | Late Graft Loss After Liver Transplantation: A Study of 432 Consecutive Patients |